2024
In Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction).
Hill K, Dunham K, Doneski K, Sue K, Thakarar K, Butner J. In Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction). Substance Use & Addiction Journal 2024, 29767342241277619. PMID: 39215532, DOI: 10.1177/29767342241277619.Peer-Reviewed Original ResearchDrug offensesDrug useCriminalization of drug useSocial safety netDecriminalization of drugsHarm reduction servicesWell-beingHarm reduction strategiesConsequences of drug useWell-being of peopleNegative consequences of drug useCommunity supervisionAddiction treatment servicesHealth of PWUDCriminal sanctionsSafety netReduction servicesTreatment servicesDecriminalizationAddiction servicesIllicit drugsOffensesNegative consequencesPWUDUnited States
2022
Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective
Narasimha VL, Butner J, Hanafi E, Farokhnia M, Bhad R, Chalabianloo F, Kouimtsidis C, Baldacchino A, Arunogiri S. Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective. BJPsych International 2022, 19: 66-69. PMID: 36287782, PMCID: PMC9540565, DOI: 10.1192/bji.2022.1.Peer-Reviewed Original Research
2021
Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A, Consortium I, Potenza M, Ekhtiari H, Baldacchino A, Abagiu A, Abouna F, Ahmed M, Al-ansari B, Abu Al-khair F, Almaqbali M, Ambekar A, Ardabili H, Arya S, Lasebikan V, Ayasreh M, Basu D, Benmebarek Z, Bhad R, Blaise M, Bonnet N, Brasch J, Broers B, Butner J, Camilleri M, Campello G, Carra G, Celic I, Chalabianloo F, Chaturvedi A, de Jesús Eduardo Noyola Cherpitel J, Clark K, Cyders M, de Bernardis E, Derry J, Dhagudu N, Dolezalova P, Dom G, Dunlop A, Elhabiby M, Elkholy H, Essien N, Farah G, Ferri M, Floros G, Friedman C, Fuderanan C, Gerra G, Ghosh A, Gogia M, Grammatikopoulos I, Grandinetti P, Guirguis A, Gutnisky D, Haber P, Hassani-Abharian P, Hooshyari Z, Ibrahim I, Ieong H, Indradewi R, Iskandar S, Jain S, James S, Javadi S, Joe K, Jokubonis D, Jovanova A, Kamal R, Kantchelov A, Kathiresan P, Katzman G, Kawale P, Kern A, Kessler F, Kim S, Kimball A, Kljucevic Z, Siste K, Lev R, Lee H, Lengvenyte A, Lev-ran S, Mabelya G, Mahi M, Maphisa J, Maremmani I, Masferrer L, McCambridge O, McGovern G, Min A, Moghanibashi-Mansourieh A, Mora-Rios J, Mudalige I, Mukherjee D, Munira P, Myers B, N J, Narasimha V, Ndionuka N, Nejatisafa A, Niaz K, Nizami A, Nuijens J, Orsolini L, Oum V, Oyemade A, Palavra I, Pant S, Paredes J, Peyron E, Quirós R, Qurishi R, Rafiq N, Rao R, Ratta-apha W, Raymond K, Reimer J, Renaldo E, Rezapour T, Robertson J, Roncero C, Roub F, Rubenstein E, Rupp C, Saenz E, Salehi M, Samartzis L, Sarubbo L, Segrec N, Shah B, Shen H, Shirasaka T, Shoptaw S, Sintango F, Sosa V, Subata E, Sztycberg N, Taghizadeh F, Teck J, Tjagvad C, Torrens M, Twala J, Vadivel R, Volpicelli J, Weijs J, Wintoniw S, Wittayanookulluk A, Wojnar M, Yasir S, Yitayih Y, Zhao M, Zonoozi A. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Frontiers In Psychiatry 2021, 12: 639393. PMID: 34025471, PMCID: PMC8135096, DOI: 10.3389/fpsyt.2021.639393.Peer-Reviewed Original ResearchSubstance use disordersHarm reduction servicesSUD treatmentHealth responseReduction servicesAdequate medication supplyCoronavirus disease 2019 (COVID-19) pandemicHarm reduction programsDisease 2019 pandemicCOVID-19 pandemicOverdose prevention interventionsSubstance use treatmentEvidence-based interventionsVulnerable groupsSyringe programsTreatment modalitiesPrevention interventionsCondom distributionPsychiatric careMedication supplyUse disordersBuprenorphine supplyOutreach servicesUse treatmentMedicine professionals